Individualized Quantified Tricuspid Valve Annuloplasty for Treating Ebstein Anomaly
|
Yiwu Liang, Linli Liu, Su Liu, Ziying Chen, Bin You, Mingzhong He, Qiwen Zhou Department of Cardiac Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Department of Cardiac Surgery, Beijing Anzhen Hospital of Capital Medical University, Beijing, Department of Electron, Professional and Technology College, Hebei Normal University, Shijiazhuang, P. R. China |
|
|
Background and aim of the study: The study aim was to evaluate whether individualized quantified selective tricuspid valve annuloplasty would be suitable for the treatment of Ebstein anomaly. |
Results: There was no hospital mortality. One patient died suddenly at 41 months after surgery, and two patients were lost to follow up; the remaining patients are still alive. During the follow up, tricuspid valve regurgitation and cardiac function were improved in all patients postoperatively, with no acquired tricuspid stenosis. |
| Individualized Quantified Tricuspid Valve Annuloplasty for Treating Ebstein Anomaly | |
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Purchase this Article
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.
Website by CHP Design, London